Citations (169)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (44)
Shweta Gore, Jennifer Blackwood, Houser Emily & Fernandez Natalia. (2023) Determinants of acute care discharge in adults with chronic obstructive pulmonary disease. Physiotherapy Theory and Practice 39:1, pages 39-48.
Read now
Read now
Sanjay Sethi, Barry J Make, Scott B Robinson, Shambhavi Kumar, Michael Pollack, Chad Moretz, Jill Dreyfus, Ann Xi, Dakota Powell & Norbert Feigler. (2022) Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 593-608.
Read now
Read now
Luca Quartuccio, Marco Sebastiani, Francesca Romana Spinelli, Fabiano Di Marco, Rosario Peluso, Salvatore D’Angelo, Alberto Cauli, Maurizio Rossini & Fabiola Atzeni. (2022) More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment. Expert Review of Clinical Immunology 18:9, pages 983-990.
Read now
Read now
Chintal H. Shah, Eberechukwu Onukwugha, Zafar Zafari, Ester Villalonga-Olives, Jeong-eun Park & Julia F. Slejko. (2022) Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population. Expert Review of Pharmacoeconomics & Outcomes Research 22:4, pages 683-690.
Read now
Read now
Kjell Larsson, Christer Janson, Karin Lisspers, Björn Ställberg, Gunnar Johansson, Florian S Gutzwiller, Karen Mezzi, Bine Kjoeller Bjerregaard & Leif Jorgensen. (2021) The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 701-713.
Read now
Read now
Sabrina Storgaard Sørensen, Line Hust Storgaard & Ulla Møller Weinreich. (2021) Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure. ClinicoEconomics and Outcomes Research 13, pages 553-564.
Read now
Read now
César Alameda, Ángel Carlos Matía & Verónica Casado. (2021) Predictors for mortality due to acute exacerbation of COPD in primary care: Derivation of a clinical prediction rule in a multicentre cohort study. European Journal of General Practice 27:1, pages 211-220.
Read now
Read now
Richard H. Stanford, Nicole M. Engel-Nitz, Timothy Bancroft & Breanna Essoi. (2020) The Identification and Cost of Acute Chronic Obstructive Pulmonary Disease Exacerbations in a United States Population Healthcare Claims Database. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:5, pages 499-508.
Read now
Read now
Melanie Schroeder, Nicole Benjamin, Laura Atienza, Chandroday Biswas, Alan Martin, John D Whalen, José Luis Izquierdo Alonso, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Alicia Huerta & Afisi S Ismaila. (2020) Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1621-1632.
Read now
Read now
Panagis Galiatsatos, Han Woo, Laura M Paulin, Amy Kind, Nirupama Putcha, Amanda J Gassett, Christopher B Cooper, Mark T Dransfield, Trisha M Parekh, Gabriela R Oates, R Graham Barr, Alejandro P Comellas, Meilan K Han, Stephen P Peters, Jerry A Krishnan, Wassim W Labaki, Meredith C McCormack, Joel D Kaufman & Nadia N Hansel. (2020) The Association Between Neighborhood Socioeconomic Disadvantage and Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 981-993.
Read now
Read now
P. van Velzen, P. Brinkman, H. H. Knobel, J. W. K. van den Berg, R. E. Jonkers, R. J. Loijmans, J. M. Prins & P.J. Sterk. (2019) Exhaled Breath Profiles Before, During and After Exacerbation of COPD: A Prospective Follow-Up Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:5-6, pages 330-337.
Read now
Read now
Jonas Comes, Guillaume Prieur, Yann Combret, Francis Edouard Gravier, Benoit Gouel, Jean Quieffin, Bouchra Lamia, Tristan Bonnevie & Clément Medrinal. (2019) Changes in Cycle-Ergometer Performance during Pulmonary Rehabilitation Predict COPD Exacerbation. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:3-4, pages 261-265.
Read now
Read now
Hee-Young Yoon, So Young Park, Chang Hoon Lee, Min-Kwang Byun, Joo Ock Na, Jae Seung Lee, Won-Yeon Lee, Kwang Ha Yoo, Ki-Suck Jung & Jin Hwa Lee. (2019) Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1389-1397.
Read now
Read now
Takudzwa Mkorombindo & Mark T Dransfield. (2019) Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1779-1787.
Read now
Read now
Bruna Wageck, Narelle S. Cox & Anne E. Holland. (2019) Recovery Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease – A Review. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:1, pages 93-103.
Read now
Read now
Laura J. Spece, Lucas M. Donovan, Matthew F. Griffith, Margaret P. Collins, Laura C. Feemster & David H. Au. (2018) Quality of Care Delivered to Veterans with COPD Exacerbation and the Association with 30-Day Readmission and Death. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:5, pages 489-495.
Read now
Read now
Thomas G Poder, Nathalie Carrier, Maryse Bélanger, Simon Couillard, Josiane Courteau, Pierre Larivée & Alain Vanasse. (2018) Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3065-3076.
Read now
Read now
Ming-Cheng Chan, Elise Chia-Hui Tan & Ming-Chin Yang. (2018) Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1079-1088.
Read now
Read now
Giuseppe Antonio Palmiotti, Donato Lacedonia, Vito Liotino, Pietro Schino, Francesco Satriano, Pier Luigi Di Napoli, Eugenio Sabato, Vincenzo Mastrosimone, Alfredo Scoditti, Mauro Carone, Elio Costantino, Emanuela Resta, Ettore Attolini & Maria Pia Foschino Barbaro. (2018) Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2455-2462.
Read now
Read now
David MG Halpin, Marc Miravitlles, Norbert Metzdorf & Bartolomé Celli. (2017) Impact and prevention of severe exacerbations of COPD: a review of the evidence. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2891-2908.
Read now
Read now
Anna Garner, Matthew Hodson, Georgios Ketsetzis, Laurence Pulle, Janelle Yorke & Angshu Bhowmik. (2017) An analysis of the economic and patient outcome impact of an integrated COPD service in east London. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1653-1662.
Read now
Read now
Amol D Dhamane, Phil Schwab, Sari Hopson, Chad Moretz, Srinivas Annavarapu, Kate Burslem, Andrew Renda & Shuchita Kaila. (2017) Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 115-122.
Read now
Read now
Marc Miravitlles, Heinrich Worth, Juan José Soler-Cataluña, David Price, Fernando De Benedetto, Nicolas Roche, Nina S. Godtfredsen, Thys van der Molen, Claes-Göran Löfdahl, Laura Padullés & Anna Ribera. (2016) The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS). COPD: Journal of Chronic Obstructive Pulmonary Disease 13:5, pages 561-568.
Read now
Read now
Hyun Lee, Chin Kook Rhee, Byung-Jae Lee, Dong-Chull Choi, Jee-Ae Kim, Sang Hyun Kim, Yoolwon Jeong, Tae-Hyung Kim, Gyu Rak Chon, Ki-Suck Jung, Sang Haak Lee, David Price, Kwang Ha Yoo & Hye Yun Park. (2016) Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 775-783.
Read now
Read now
Margaret K Pasquale, Yihua Xu, Christine L Baker, Kelly H Zou, John G Teeter, Andrew M Renda, Cralen C Davis, Theodore C Lee & Joel Bobula. (2016) COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 111-121.
Read now
Read now
Johanna Laue, Hasse Melbye, Peder A Halvorsen, Elena A Andreeva, Maciek Godycki-Cwirko, Anja Wollny, Nick A Francis, Mark Spigt, Kenny Kung & Mette Bech Risør. (2016) How do general practitioners implement decision-making regarding COPD patients with exacerbations? An international focus group study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3109-3119.
Read now
Read now
Xiaoying Chen, Na Wang, Yue Chen, Tian Xiao, Chaowei Fu & Biao Xu. (2016) Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2625-2632.
Read now
Read now
Suk Hyeon Jeong, Hyun Lee, KC Carriere, Sun Hye Shin, Seong Mi Moon, Byeong-Ho Jeong, Won-Jung Koh & Hye Yun Park. (2016) Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1857-1865.
Read now
Read now
Dimitra Nikoletou, William D.-C. Man, Naveed Mustfa, Julie Moore, Gerrard Rafferty, Robert L. Grant, Lorna Johnson & John Moxham. (2016) Evaluation of the effectiveness of a home-based inspiratory muscle training programme in patients with chronic obstructive pulmonary disease using multiple inspiratory muscle tests. Disability and Rehabilitation 38:3, pages 250-259.
Read now
Read now
Yaozhu J. Chen, Charles Makin, Vamsi K. Bollu, Maryam Navaie & Bartolome R. Celli. (2016) Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting 2-agonists. Journal of Medical Economics 19:1, pages 11-20.
Read now
Read now
Amol D Dhamane, Chad Moretz, Yunping Zhou, Kate Burslem, Kim Saverno, Gagan Jain, Andrew Renda & Shuchita Kaila. (2015) COPD exacerbation frequency and its association with health care resource utilization and costs. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2609-2618.
Read now
Read now
Seppo T Rinne, Chuan-Fen Liu, Laura C Feemster, Bridget F Collins, Christopher L Bryson, Thomas G O’Riordan & David H Au. (2015) Thiazolidinediones are associated with a reduced risk of COPD exacerbations. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1591-1597.
Read now
Read now
Pere Almagro, Carme Hernandez, Pable Martinez-Cambor, Ricard Tresserras & Joan Escarrabill. (2015) Seasonality, ambient temperatures and hospitalizations for acute exacerbation of COPD: a population-based study in a metropolitan area. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 899-908.
Read now
Read now
Yogesh Suresh Punekar, Keele Wurst & Amit Shukla. (2015) Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:3, pages 271-280.
Read now
Read now
Jeetvan G Patel, Saurabh P Nagar & Anand A Dalal. (2014) Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 289-300.
Read now
Read now
Olivia Thorpe, Saravana Kumar & Kylie Johnston. (2014) Barriers to and enablers of physical activity in patients with COPD following a hospital admission: a qualitative study. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 115-128.
Read now
Read now
David L. Gold, Michelle Dawson, Harry Yang, Joseph Parker & David L. Gossage. (2014) Clinical Trial Simulation To Assist In COPD Trial Planning And Design With A Biomarker-Based Diagnostic: When To Pull The Trigger?. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:2, pages 226-235.
Read now
Read now
Anthony J Guarascio, Shauntá M Ray, Christopher K Finch & Timothy H Self. (2013) The clinical and economic burden of chronic obstructive pulmonary disease in the USA. ClinicoEconomics and Outcomes Research 5, pages 235-245.
Read now
Read now
Alicia K. Gerke, Fan Tang, Ming Yang, Eric D. Foster, Joseph E. Cavanaugh & Philip M. Polgreen. (2013) Predicting Chronic Obstructive Pulmonary Disease Hospitalizations Based on Concurrent Influenza Activity. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:5, pages 573-580.
Read now
Read now
Caitlyn T Solem, Shawn X Sun, Lavanya Sudharshan, Cynthia Macahilig, Monica Katyal & Xin Gao. (2013) Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 641-652.
Read now
Read now
Prasadini N. Perera, Edward P. Armstrong, Duane L. Sherrill & Grant H. Skrepnek. (2012) Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality. COPD: Journal of Chronic Obstructive Pulmonary Disease 9:2, pages 131-141.
Read now
Read now
Barbara P Yawn & Byron Thomashow. (2011) Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians. International Journal of General Medicine 4, pages 665-676.
Read now
Read now
Kathryn Gaebel, R. Andrew McIvor, Feng Xie, Gord Blackhouse, Diana Robertson, Nazila Assasi, Paul Hernandez & Ron Goeree. (2011) Triple Therapy for the Management of COPD: A Review. COPD: Journal of Chronic Obstructive Pulmonary Disease 8:3, pages 206-243.
Read now
Read now
Anand A Dalal, Fang Liu & Aylin A Riedel. (2011) Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009. International Journal of Chronic Obstructive Pulmonary Disease 6, pages 533-542.
Read now
Read now
Articles from other publishers (125)
Sergi Pascual-Guardia, Francesco Amati, Judith Marin-Corral, Stefano Aliberti, Joaquim Gea, Nilam J. Soni, Alejandro Rodriguez, Oriol Sibila, Francisco Sanz, Giovanni Sotgiu, Pedro J. Marcos, Ane Uranga, Branislava Milenkovic, Christian N. Meyer, Martin Kolditz, Antonio R. Anzueto & Marcos I. Restrepo. (2023) Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia. Archivos de Bronconeumología 59:2, pages 90-100.
Crossref
Crossref
Yurina Murakami, Hideki Yasui, Jun Sato, Tomohiro Uto, Naoki Inui, Takafumi Suda & Shiro Imokawa. (2023) Predictors of poor clinical outcomes including in-hospital death and low ability to perform activities of daily living at discharge in hospitalized patients with chronic obstructive pulmonary disease exacerbation. Therapeutic Advances in Respiratory Disease 17, pages 175346662311729.
Crossref
Crossref
Michal Shani, Doron Comaneshter & Michael J. Segel. (2022) The importance of having good quality indicators for care of patients with COPD: a look at hospital readmission rates. Israel Journal of Health Policy Research 11:1.
Crossref
Crossref
Yong-Li Gu, Zeng-Xian Sun, Ying Sun, Yan Wen, Xin Guan, Dao-Li Jiang, Cong Cheng & Huan Gu. (2022) A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Arwel W Jones, Joanne E McKenzie, Christian R Osadnik, Elizabeth Stovold, Narelle S Cox, Angela T Burge, Aroub Lahham, Joanna YT Lee, Mariana Hoffman & Anne E Holland. (2022) Non-pharmacological interventions for the prevention of hospitalisations in stable chronic obstructive pulmonary disease: component network meta-analysis. Cochrane Database of Systematic Reviews 2022:7.
Crossref
Crossref
José Luis Izquierdo, José Miguel Rodríguez, Carlos Almonacid, María Benavent, Ramón Arroyo-Espliguero & Alvar Agustí. (2022) Real-life burden of hospitalisations due to COPD exacerbations in Spain. ERJ Open Research 8:3, pages 00141-2022.
Crossref
Crossref
Sunil K. Chhabra & Devi Jyoti Dash. (2022) Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Causes and Impacts. The Indian Journal of Chest Diseases and Allied Sciences 56:2, pages 93-104.
Crossref
Crossref
Beibei Song, Huiran Zhang, Libin Jiao, Zeng Jing, Honglin Li & Siyu Wu. (2022) Effect of high-level fine particulate matter and its interaction with meteorological factors on AECOPD in Shijiazhuang, China. Scientific Reports 12:1.
Crossref
Crossref
Jade Schrijver, Anke Lenferink, Marjolein Brusse-Keizer, Marlies Zwerink, Paul DLPM van der Valk, Job van der Palen & Tanja W Effing. (2022) Self-management interventions for people with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2023:3.
Crossref
Crossref
Alastair Watson & Tom M.A. Wilkinson. (2022) Digital healthcare in COPD management: a narrative review on the advantages, pitfalls, and need for further research. Therapeutic Advances in Respiratory Disease 16, pages 175346662210754.
Crossref
Crossref
Claire M. Nolan & William D.C. Man. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
650
662
.
Chuchu Zhang, Yalei Wang, Meng Zhang, Xiaojie Su, Ting Lei, Haichuan Yu & Jian Liu. (2021) Monoclonal Antibodies Targeting IL-5 or IL-5Rα in Eosinophilic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
William D-C. Man & Arwel W. Jones. 2021. Pulmonary Rehabilitation. Pulmonary Rehabilitation
165
181
.
Ana Oliveira, Shirley Quach, Sanaa Alsubheen, Sabrina Dasouki, Jan Walker, Dina Brooks & Roger Goldstein. (2021) Rapid access rehabilitation after exacerbations of COPD – A qualitative study. Respiratory Medicine 186, pages 106532.
Crossref
Crossref
Christina Hoffmann, Uta Liebers, Philipp Humbsch, Marija Drozdek, Georg Bölke, Peter Hoffmann, Adrien Holzgreve, Gavin C. Donaldson & Christian Witt. (2021) An adaptation strategy to urban heat: hospital rooms with radiant cooling accelerate patient recovery. ERJ Open Research 7:3, pages 00881-2020.
Crossref
Crossref
Peter Schenk, Alexander O. Spiel, Felix Hüttinger, Micheline Gmeiner, Josefine Fugger, Martina Pichler, Gernot Pichler, Susanne Schmeikal, Wolfgang Janistyn, Stefan Schügerl, Constantin Sajdik & Harald Herkner. (2021) Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study. European Respiratory Journal 58:1, pages 2001798.
Crossref
Crossref
Adil Adatia, Mustafaa Wahab, Izza Shahid, Ali Moinuddin, Kieran J. Killian & Imran Satia. (2021) Effects of cigarette smoke exposure on pulmonary physiology, muscle strength and exercise capacity in a retrospective cohort with 30,000 subjects. PLOS ONE 16:6, pages e0250957.
Crossref
Crossref
Gang Luo, Bryan L Stone, Xiaoming Sheng, Shan He, Corinna Koebnick & Flory L Nkoy. (2021) Using Computational Methods to Improve Integrated Disease Management for Asthma and Chronic Obstructive Pulmonary Disease: Protocol for a Secondary Analysis. JMIR Research Protocols 10:5, pages e27065.
Crossref
Crossref
Domingo Orozco-Beltrán, Juan Manuel Arriero-Marin, Concepción Carratalá-Munuera, Juan J. Soler-Cataluña, Adriana Lopez-Pineda, Vicente F. Gil-Guillén & Jose A. Quesada. (2021) Trends in Hospital Admissions for Chronic Obstructive Pulmonary Disease in Men and Women in Spain, 1998 to 2018. Journal of Clinical Medicine 10:7, pages 1529.
Crossref
Crossref
Mathieu Fieldes, Chloé Bourguignon, Said Assou, Amel Nasri, Aurélie Fort, Isabelle Vachier, John De Vos, Engi Ahmed & Arnaud Bourdin. (2021) Targeted therapy in eosinophilic chronic obstructive pulmonary disease. ERJ Open Research 7:2, pages 00437-2020.
Crossref
Crossref
Amanda R van Buul, Caroline Derksen, Ouke Hoedemaker, Oscar van Dijk, Niels H Chavannes & Marise J Kasteleyn. (2021) eHealth Program to Reduce Hospitalizations Due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Retrospective Study. JMIR Formative Research 5:3, pages e24726.
Crossref
Crossref
Elizabeth Lee. (2021) Defining Phenotypes of COPD Through Anatomic and Functional Imaging. Academic Radiology 28:3, pages 379-380.
Crossref
Crossref
Laura Kooij, Petra J E Vos, Antoon Dijkstra & Wim H van Harten. (2021) Effectiveness of a Mobile Health and Self-Management App for High-Risk Patients With Chronic Obstructive Pulmonary Disease in Daily Clinical Practice: Mixed Methods Evaluation Study. JMIR mHealth and uHealth 9:2, pages e21977.
Crossref
Crossref
Jennifer Alison. (2020)
Reducing hospital readmissions for
COPD
exacerbations: The role of exercise and ongoing support
. Respirology 26:1, pages 10-11.
Crossref
Crossref
Fanny Wai‐San Ko, Wilson Tam, Eddy H.S. Siu, Ka‐Pang Chan, Jenny Chun‐Li Ngai, So‐Shan Ng, Tat On Chan & David Shu‐Cheong Hui. (2020)
Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with
COPD
: A randomized controlled trial
. Respirology 26:1, pages 72-79.
Crossref
Crossref
Lee Gazourian, William B. Thedinger, Shawn M. Regis, Elizabeth J. Pagura, Lori Lyn Price, Melissa Gawlik, Cristina F. Stefanescu, Carla Lamb, Kimberly M. Rieger-Christ, Harpreet Singh, Marcel Casasola, Alexander R. Walker, Arashdeep Rupal, Avignat S. Patel, Carolyn E. Come, Ava M. Sanayei, William P. Long, Giulia S. Rizzo, Andrea B. McKee, George R. Washko, Raul San Jose Estepar, Christoph Wald, Brady J. McKee, Carey C. Thomson & Timothy N. Liesching. (2021) Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study. Respiratory Medicine 176, pages 106245.
Crossref
Crossref
Sofia Guerra-Paiva, Filipe Dias, Daniela Costaa, Vitor Santos & Carolina Santos. (2021) DPO2 Project: telehealth to enhance the social role of physical activity in people living with COPD. Procedia Computer Science 181, pages 869-875.
Crossref
Crossref
Zihui Wang, Yumin Zhou, Yongbo Zhang, Xiaoliang Huang, Xianzhong Duan, Duohong Chen, Yubo Ou, Longhui Tang, Shiliang Liu, Wei Hu, Chenghao Liao, Yijia Zheng, Long Wang, Min Xie, Jinzhen Zheng, Sha Liu, Ming Luo, Fan Wu, Zhishan Deng, Heshen Tian, Jieqi Peng, Huajing Yang, Shan Xiao, Xinwang Wang, Nanshan Zhong & Pixin Ran. (2021) Association of change in air quality with hospital admission for acute exacerbation of chronic obstructive pulmonary disease in Guangdong, China: A province-wide ecological study. Ecotoxicology and Environmental Safety 208, pages 111590.
Crossref
Crossref
Yvonne JG Korpershoek, Tjitske Holtrop, Sigrid CJM Vervoort, Lisette Schoonhoven, Marieke J Schuurmans & Jaap CA Trappenburg. (2020) Early-Stage Feasibility of a Mobile Health Intervention (Copilot) to Enhance Exacerbation-Related Self-Management in Patients With Chronic Obstructive Pulmonary Disease: Multimethods Approach. JMIR Formative Research 4:11, pages e21577.
Crossref
Crossref
Marina Malheiro Cruz & Marcos Pereira. (2020) Epidemiology of Chronic Obstructive Pulmonary Disease in Brazil: a systematic review and meta-analysis. Ciência & Saúde Coletiva 25:11, pages 4547-4557.
Crossref
Crossref
Antonio Anzueto & Alan Kaplan. (2020) Dual bronchodilators in chronic obstructive pulmonary disease: Evidence from randomized controlled trials and real-world studies. Respiratory Medicine: X 2, pages 100016.
Crossref
Crossref
Cuiping Fu, Xin Liu, Qingqing Zhu, Xu Wu, Shengyu Hao, Liang Xie & Shanqun Li. (2020) Efficiency of High-Flow Nasal Cannula on Pulmonary Rehabilitation in COPD Patients: A Meta-Analysis. BioMed Research International 2020, pages 1-9.
Crossref
Crossref
Walter Sepúlveda‐Loyola, Christian Osadnik, Steven Phu, Andrea A. Morita, Gustavo Duque & Vanessa S. Probst. (2020) Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysis. Journal of Cachexia, Sarcopenia and Muscle 11:5, pages 1164-1176.
Crossref
Crossref
Andrew I. Ritchie & Jadwiga A. Wedzicha. (2020) Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clinics in Chest Medicine 41:3, pages 421-438.
Crossref
Crossref
Andrew I. Ritchie, Simon E. Brill, Ben H. Vlies, Lydia J. Finney, James P. Allinson, Luana Alves-Moreira, Dexter J. Wiseman, Paul P. Walker, Emma Baker, Sarah L. Elkin, Patrick Mallia, Martin Law, Gavin C. Donaldson, Peter M. A. Calverley & Jadwiga A. Wedzicha. (2020) Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial. American Journal of Respiratory and Critical Care Medicine 202:4, pages 549-557.
Crossref
Crossref
William D.-C. Man, Claire M. Nolan & Milo A. Puhan. 2020. Pulmonary Rehabilitation. Pulmonary Rehabilitation
241
246
.
Girija Syamlal, Anasua Bhattacharya & Katelynn E. Dodd. (2020) Medical Expenditures Attributed to Asthma and Chronic Obstructive Pulmonary Disease Among Workers — United States, 2011–2015. MMWR. Morbidity and Mortality Weekly Report 69:26, pages 809-814.
Crossref
Crossref
Oliver N. Keene, Stephen Ruberg, Alexander Schacht, Mouna Akacha, Rachael Lawrance, Anna Berglind & David Wright. (2020) What matters most? Different stakeholder perspectives on estimands for an invented case study in COPD. Pharmaceutical Statistics 19:4, pages 370-387.
Crossref
Crossref
Yvonne J G Korpershoek, Sander Hermsen, Lisette Schoonhoven, Marieke J Schuurmans & Jaap C A Trappenburg. (2020) User-Centered Design of a Mobile Health Intervention to Enhance Exacerbation-Related Self-Management in Patients With Chronic Obstructive Pulmonary Disease (Copilot): Mixed Methods Study. Journal of Medical Internet Research 22:6, pages e15449.
Crossref
Crossref
Tianjiao Shen, Milan Bimali, Mohammed Faramawi & Mohammed S. Orloff. (2020) Consumption of Vitamin K and Vitamin A Are Associated With Reduced Risk of Developing Emphysema: NHANES 2007–2016. Frontiers in Nutrition 7.
Crossref
Crossref
Yong Suk Jo, Chin Kook Rhee, Kyung Joo Kim, Kwang Ha Yoo & Yong-Bum Park. (2020) Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 14, pages 175346662096168.
Crossref
Crossref
Ruth Ruttenberg. (2020) The Social and Economic Impact of Chronic Obstructive Pulmonary Disease on Maintenance-of-Way Railroad Workers. Journal of Occupational & Environmental Medicine 62:1, pages 58-63.
Crossref
Crossref
Claudia Gregoriano, Thomas Dieterle, Anna-Lisa Breitenstein, Selina Dürr, Amanda Baum, Stéphanie Giezendanner, Sabrina Maier, Anne Leuppi-Taegtmeyer, Isabelle Arnet, Kurt E. Hersberger & Jörg D. Leuppi. (2019) Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial. Respiratory Research 20:1.
Crossref
Crossref
Riju Ray, Beth Hahn, Richard H. Stanford, John White, Breanna Essoi & Alyssa Goolsby Hunter. (2019) Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study. Pulmonary Therapy 5:2, pages 191-200.
Crossref
Crossref
Allison Keshishian, Lin Xie, Carole Dembek & Huseyin Yuce. (2019) Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators. Clinical Therapeutics 41:11, pages 2283-2296.
Crossref
Crossref
de Miguel-Diez, Jiménez-García, Hernández-Barrera, Puente-Maestu, Girón-Matute, de Miguel-Yanes, Méndez-Bailón, Villanueva-Orbaiz, Albaladejo-Vicente & López-de-Andrés. (2019) Trends in the Use and Outcomes of Mechanical Ventilation among Patients Hospitalized with Acute Exacerbations of COPD in Spain, 2001 to 2015. Journal of Clinical Medicine 8:10, pages 1621.
Crossref
Crossref
Arash Samarghandi & Rehan Qayyum. (2023) Effect of Hospital Readmission Reduction Program on Hospital Readmissions and Mortality Rates. Journal of Hospital Medicine 14:9.
Crossref
Crossref
Yipeng Ding, Quanni Li, Cibing Wu, Wei Wang, Jie Zhao, Qiong Feng, Xiaoman Zhou, Yufei Xie, Mei Lin, Ping He & Pingdong Xie. (2019)
TERT
gene polymorphisms are associated with chronic obstructive pulmonary disease risk in the Chinese Li population
. Molecular Genetics & Genomic Medicine 7:8.
Crossref
Crossref
Aureliano Paolo Finch, Patricia van Velzen, Gerben ter Riet, Peter J. Sterk, Jan M. Prins & Judith E. Bosmans. (2018) Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD: A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial. PharmacoEconomics 37:5, pages 689-699.
Crossref
Crossref
Aina Rigo & Berta Paz-Lourido. (2019) ¿Por qué la rehabilitación respiratoria no llega a todos los pacientes de enfermedad pulmonar obstructiva crónica que lo necesitan? Revisión de la literatura. Revista de la Facultad de Medicina 67:2, pages 325-332.
Crossref
Crossref
Katy C. Norman, Christine M. Freeman, Neha S. Bidthanapally, MeiLan K. Han, Fernando J. Martinez, Jeffrey L. Curtis & Kelly B. Arnold. (2019) Inference of Cellular Immune Environments in Sputum and Peripheral Blood Associated with Acute Exacerbations of COPD. Cellular and Molecular Bioengineering 12:2, pages 165-177.
Crossref
Crossref
Roberto Dal Negro. (2019) COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power. Healthcare 7:1, pages 35.
Crossref
Crossref
Anna E. WallaceShuchita KailaValentina BayerAsif ShaikhMayura U. ShindeVincent J. WilleyMark B. NapierJoseph R. Singer. (2019) Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population. Journal of Managed Care & Specialty Pharmacy 25:2, pages 205-217.
Crossref
Crossref
Parvaiz A. Koul, Aqsa Amin Nowshehri, Umar H. Khan, Rafi A. Jan & S. U. Shah. (2019) Cost of Severe Chronic Obstructive Pulmonary Disease Exacerbations in a High Burden Region in North India. Annals of Global Health 85:1.
Crossref
Crossref
Eneida M. Harrison & Victor Kim. (2019) Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease. Respiratory Medicine: X 1, pages 100009.
Crossref
Crossref
Chau Ngo, Thuy Thi Bui, Giap Vu, Hanh Chu, Phuong Phan, Ha Ngoc Pham, Giang Vu, Long Nguyen, Giang Ha, Bach Tran, Carl Latkin, Cyrus Ho & Roger Ho. (2018) Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam. International Journal of Environmental Research and Public Health 16:1, pages 88.
Crossref
Crossref
Juthaporn Cowan, Sunita Mulpuru, Shawn Aaron, Gonzalo Alvarez, Antonio Giulivi, Vicente Corrales-Medina, Venkatesh Thiruganasambandamoorthy, Kednapa Thavorn, Ranjeeta Mallick & D. William Cameron. (2018) Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations. Pilot and Feasibility Studies 4:1.
Crossref
Crossref
Pierre-Régis Burgel, Caroline Laurendeau, Chantal Raherison, Claire Fuhrman & Nicolas Roche. (2018) An attempt at modeling COPD epidemiological trends in France. Respiratory Research 19:1.
Crossref
Crossref
Y. J. G. Korpershoek, S. C. J. M. Vervoort, J. C. A. Trappenburg & M. J. Schuurmans. (2018) Perceptions of patients with chronic obstructive pulmonary disease and their health care providers towards using mHealth for self-management of exacerbations: a qualitative study. BMC Health Services Research 18:1.
Crossref
Crossref
Francesca Polverino & Bartolome Celli. (2018) The Challenge of Controlling the COPD Epidemic: Unmet Needs. The American Journal of Medicine 131:9, pages 1-6.
Crossref
Crossref
David M. Jacobs, Katia Noyes, Jiwei Zhao, Walter Gibson, Timothy F. Murphy, Sanjay Sethi & Heather M. Ochs-Balcom. (2018) Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions Database. Annals of the American Thoracic Society 15:7, pages 837-845.
Crossref
Crossref
Yochai Adir, Omar Hakrush, Michal Shteinberg, Sonia Schneer & Alvar Agusti. (2018) Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study. ERJ Open Research 4:3, pages 00022-2018.
Crossref
Crossref
Heather M. Young, Fumin Guo, Rachel L. Eddy, Geoffrey Maksym & Grace Parraga. (2018) Oscillometry and pulmonary MRI measurements of ventilation heterogeneity in obstructive lung disease: relationship to quality of life and disease control. Journal of Applied Physiology 125:1, pages 73-85.
Crossref
Crossref
Ana Oliveira, João Rodrigues & Alda Marques. (2018) Enhancing our understanding of computerised adventitious respiratory sounds in different COPD phases and healthy people. Respiratory Medicine 138, pages 57-63.
Crossref
Crossref
Alpesh N. Amin, Vamsi Bollu, Michael D. Stensland, Logan Netzer & Vaidyanathan Ganapathy. (2018) Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease. American Journal of Health-System Pharmacy 75:6, pages 359-366.
Crossref
Crossref
Andrea Aiello, Daniela Ritrovato & Claudia Pitotti. (2018) Budget impact model of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease in Italy based on the FLAME study. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 2018, pages 228424031880480.
Crossref
Crossref
Thomas G Poder, Christian R C Kouakou, Pierre-Alexandre Bouchard, Véronique Tremblay, Sébastien Blais, François Maltais & François Lellouche. (2018)
Cost-effectiveness of FreeO
2
in patients with chronic obstructive pulmonary disease hospitalised for acute exacerbations: analysis of a pilot study in Quebec
. BMJ Open 8:1, pages e018835.
Crossref
Crossref
Roberto W. Dal Negro & Claudio F. Donner. 2018. Textbook of Pulmonary Rehabilitation. Textbook of Pulmonary Rehabilitation
273
282
.
Muhammad Ahsan Zafar, Ralph J Panos, Jonathan Ko, Lisa C Otten, Anthony Gentene, Maria Guido, Katherine Clark, Caroline Lee, Jamie Robertson & Evaline A Alessandrini. (2017) Reliable adherence to a COPD care bundle mitigates system-level failures and reduces COPD readmissions: a system redesign using improvement science. BMJ Quality & Safety 26:11, pages 908-918.
Crossref
Crossref
Anke Lenferink, Marjolein Brusse-Keizer, Paul DLPM van der Valk, Peter A Frith, Marlies Zwerink, Evelyn M Monninkhof, Job van der Palen & Tanja W Effing. (2017) Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2017:8.
Crossref
Crossref
Seppo T. Rinne, Anashua R. Elwy, Lori A. Bastian, Edwin S. Wong, Renda S. Wiener & Chuan-Fen Liu. (2017) Impact of Multisystem Health Care on Readmission and Follow-up Among Veterans Hospitalized for Chronic Obstructive Pulmonary Disease. Medical Care 55:Suppl 1, pages S20-S25.
Crossref
Crossref
Elizabeth Baker & Francis Fatoye. (2017) Clinical and cost effectiveness of nurse-led self-management interventions for patients with copd in primary care: A systematic review. International Journal of Nursing Studies 71, pages 125-138.
Crossref
Crossref
Vicky Thomas, Eran Gefen, Gokul Gopalan, Rafael Mares, Rosie McDonald, Simon Wan Yau Ming & David B. Price. (2017) Ipratropium/Salbutamol Comparator Versus Originator for Chronic Obstructive Pulmonary Disease Exacerbations: USA Observational Cohort Study Using the Clinformatics™ Health Claims Database. Pulmonary Therapy 3:1, pages 187-205.
Crossref
Crossref
Jennifer A. Alison, Zoe J. McKeough, Kylie Johnston, Renae J. McNamara, Lissa M. Spencer, Sue C. Jenkins, Catherine J. Hill, Vanessa M. McDonald, Peter Frith, Paul Cafarella, Michelle Brooke, Helen L. Cameron-Tucker, Sarah Candy, Nola Cecins, Andrew S.L. Chan, Marita T. Dale, Leona M. Dowman, Catherine Granger, Simon Halloran, Peter Jung, Annemarie L. Lee, Regina Leung, Tamara Matulick, Christian Osadnik, Mary Roberts, James Walsh, Sally Wootton & Anne E. Holland. (2017) Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology 22:4, pages 800-819.
Crossref
Crossref
A. Bourdin & N. Molinari. (2017) Quelles sont les conséquences socio-économiques des exacerbations de BPCO ?. Revue des Maladies Respiratoires 34:4, pages 338-342.
Crossref
Crossref
Melissa Kargiannakis, Deborah A Fitzsimmons, Claire L Bentley & Gail A Mountain. (2017) Does Telehealth Monitoring Identify Exacerbations of Chronic Obstructive Pulmonary Disease and Reduce Hospitalisations? An Analysis of System Data. JMIR Medical Informatics 5:1, pages e8.
Crossref
Crossref
Amber L. Martin, Jessica Marvel, Kyle Fahrbach, Sarah M. Cadarette, Teresa K. Wilcox & James F. Donohue. (2016) The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis. Respiratory Research 17:1.
Crossref
Crossref
César Alameda, Ángel Carlos Matía & Verónica Casado. (2016) Predictors for mortality due to acute exacerbation of COPD in primary care: protocol for the derivation of a clinical prediction rule. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Anna Dvorkin-Gheva, Gilles Vanderstocken, Ali Önder Yildirim, Corry-Anke Brandsma, Ma'en Obeidat, Yohan Bossé, John A. Hassell & Martin R. Stampfli. (2016) Total particulate matter concentration skews cigarette smoke's gene expression profile. ERJ Open Research 2:4, pages 00029-2016.
Crossref
Crossref
Daniel Sanchez-Morillo, Miguel A Fernandez-Granero & Antonio Leon-Jimenez. (2016) Use of predictive algorithms in-home monitoring of chronic obstructive pulmonary disease and asthma. Chronic Respiratory Disease 13:3, pages 264-283.
Crossref
Crossref
Jadwiga A. Wedzicha, Donald Banerji, Kenneth R. Chapman, J?rgen Vestbo, Nicolas Roche, R. Timothy Ayers, Chau Thach, Robert Fogel, Francesco Patalano & Claus F. Vogelmeier. (2016) Indacaterol?Glycopyrronium versus Salmeterol?Fluticasone for COPD. New England Journal of Medicine 374:23, pages 2222-2234.
Crossref
Crossref
Marlies Zwerink, Huib AM Kerstjens, Job van der Palen, Paul van der Valk, Marjolein Brusse-Keizer, Gerhard Zielhuis & Tanja Effing. (2016) (Cost-)effectiveness of self-treatment of exacerbations in patients with COPD: 2 years follow-up of a RCT. Respirology 21:3, pages 497-503.
Crossref
Crossref
Nguyen Van Tho, Hye Yun Park & Yasutaka Nakano. (2016) Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge. Respirology 21:3, pages 410-418.
Crossref
Crossref
Sergio Iannazzo, Chiara Distante & Angelo Guido Corsico. (2016) Costs of Tiotropium Bromide Delivered via the Respimat® Inhaler in COPD Patients in Italy. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 3:2, pages GRHTA.5000220.
Crossref
Crossref
Melina Dritsaki, Vicki Johnson-Warrington, Katy Mitchell, Sally Singh & Karen Rees. (2015) An economic evaluation of a self-management programme of activity, coping and education for patients with chronic obstructive pulmonary disease. Chronic Respiratory Disease 13:1, pages 48-56.
Crossref
Crossref
Nicolino Ambrosino, Richard Casaburi, Alfredo Chetta, Enrico Clini, Claudio F. Donner, Michael Dreher, Roger Goldstein, Amal Jubran, Linda Nici, Caroline A. Owen, Carolyn Rochester, Martin J. Tobin, Guido Vagheggini, Michele Vitacca & Richard ZuWallack. (2015) 8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 2. Multidisciplinary Respiratory Medicine 10:1.
Crossref
Crossref
Christine M. Freeman, Carlos H. Martinez, Jill C. Todt, Fernando J. Martinez, MeiLan K. Han, Deborah L. Thompson, Lisa McCloskey & Jeffrey L. Curtis. (2015) Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood. Respiratory Research 16:1.
Crossref
Crossref
Juthaporn Cowan, Logan Gaudet, Sunita Mulpuru, Vicente Corrales-Medina, Steven Hawken, Chris Cameron, Shawn D. Aaron & D. William Cameron. (2015) A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease. PLOS ONE 10:11, pages e0142205.
Crossref
Crossref
Miguel Fernandez-Granero, Daniel Sanchez-Morillo & Antonio Leon-Jimenez. (2015) Computerised Analysis of Telemonitored Respiratory Sounds for Predicting Acute Exacerbations of COPD. Sensors 15:10, pages 26978-26996.
Crossref
Crossref
William D-C. Man, Milo A. Puhan, Samantha L. Harrison, Rachel E. Jordan, Jennifer K. Quint & Sally J. Singh. (2015) Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?. ERJ Open Research 1:2, pages 00050-2015.
Crossref
Crossref
Vania Ranjbar, Anna Hjalmarsson, Henry Ascher & Ann Ekberg-Jansson. (2015) Chronic obstructive pulmonary disease mobile care: A participant-focussed and human rights-based evaluation. Health Services Management Research 28:3-4, pages 58-66.
Crossref
Crossref
Wenjia Chen, Jamie Thomas, Mohsen Sadatsafavi & J Mark FitzGerald. (2015) Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. The Lancet Respiratory Medicine 3:8, pages 631-639.
Crossref
Crossref
Nguyen Van Tho, Emiko Ogawa, Le Thi Huyen Trang, Yasushi Ryujin, Rie Kanda, Hiroaki Nakagawa, Kenichi Goto, Kentaro Fukunaga, Yuichi Higami, Ruriko Seto, Hiroshi Wada, Masafumi Yamaguchi, Taishi Nagao, Le Thi Tuyet Lan & Yasutaka Nakano. (2015) A Mixed Phenotype of Airway Wall Thickening and Emphysema Is Associated with Dyspnea and Hospitalization for Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 12:7, pages 988-996.
Crossref
Crossref
Paul W. Jones. (2015) Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 9:3, pages 84-96.
Crossref
Crossref
Anke Lenferink, Marjolein Brusse-Keizer, Paul DLPM van der Valk, Peter A Frith, Marlies Zwerink, Evelyn M Monninkhof, Job van der Palen & Tanja Effing. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
J. Christian Virchow, Vibeke Backer, Frédéric de Blay, Piotr Kuna, Christian Ljørring, Jesus L. Prieto & Hanne H. Villesen. (2015) Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement. Respiratory Medicine 109:5, pages 547-556.
Crossref
Crossref
Daniel Sanchez-Morillo, Miguel Angel Fernandez-Granero & Antonio León Jiménez. (2015) Detecting COPD exacerbations early using daily telemonitoring of symptoms and k-means clustering: a pilot study. Medical & Biological Engineering & Computing 53:5, pages 441-451.
Crossref
Crossref
Mathieu C. Morissette, Pamela Shen, Danya Thayaparan & Martin R. Stämpfli. (2015) Impacts of peroxisome proliferator-activated receptor-γ activation on cigarette smoke-induced exacerbated response to bacteria. European Respiratory Journal 45:1, pages 191-200.
Crossref
Crossref
Jadwiga A. Wedzicha, Roland Buhl, David Lawrence & David Young. (2015) Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trials. Respiratory Medicine 109:1, pages 105-111.
Crossref
Crossref
Miguel Angel Fernandez-Granero, Daniel Sanchez-Morillo, Miguel Angel Lopez-Gordo & Antonio Leon. 2015. Artificial Computation in Biology and Medicine. Artificial Computation in Biology and Medicine
305
311
.
Stefano Carlone, Bruno Balbi, Michela Bezzi, Marco Brunori, Stefano Calabro, Maria Pia Foschino Barbaro, Claudio Micheletto, Salvatore Privitera, Roberto Torchio, Pietro Schino & Andrea Vianello. (2014) Health and social impacts of COPD and the problem of under-diagnosis. Multidisciplinary Respiratory Medicine 9:1.
Crossref
Crossref
Emmylou Beekman, Ilse Mesters, Erik JM Hendriks, Jean WM Muris, Geertjan Wesseling, Silvia MAA Evers, Guus M Asijee, Annemieke Fastenau, Hannah N Hoffenkamp, Rik Gosselink, Onno CP van Schayck & Rob A de Bie. (2014) Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
Paul W. Jones, Rosa Lamarca, Ferran Chuecos, Dave Singh, Alvar Agustí, Eric D. Bateman, Gonzalo de Miquel, Cynthia Caracta & Esther Garcia Gil. (2014) Characterisation and impact of reported and unreported exacerbations: results from ATTAIN. European Respiratory Journal 44:5, pages 1156-1165.
Crossref
Crossref
Francisco Jódar-Sánchez, Francisco Ortega, Carlos Parra, Cristina Gómez-Suárez, Patricia Bonachela, Sandra Leal, Pablo Pérez, Ana Jordán & Emilia Barrot. (2014) Cost-utility analysis of a telehealth programme for patients with severe chronic obstructive pulmonary disease treated with long-term oxygen therapy. Journal of Telemedicine and Telecare 20:6, pages 307-316.
Crossref
Crossref
Cecile M.A. Utens, Onno C.P. van Schayck, Lucas M.A. Goossens, Maureen P.H.M. Rutten-van M?lken, Dirk R.A.J. DeMunck, Wiel Seezink, Monique van Vliet & Frank W.J.M. Smeenk. (2014) Informal caregiver strain, preference and satisfaction in hospital-at-home and usual hospital care for COPD exacerbations: Results of a randomised controlled trial. International Journal of Nursing Studies 51:8, pages 1093-1102.
Crossref
Crossref
Andriana I. Papaioannou, Stamatoula Tsikrika, Konstantinos Bartziokas, Foteini Karakontaki, Emmanouil Kastanakis, Filia Diamantea, Aikaterini Haniotou, Spyros Papiris, Vlassis Polychronopoulos, Stelios Loukides & Konstantinos Kostikas. (2014) Collateral Damage: Depressive Symptoms in the Partners of COPD Patients. Lung 192:4, pages 519-524.
Crossref
Crossref
Takashi Angata, Takeo Ishii, Congxiao Gao, Kazuaki Ohtsubo, Shinobu Kitazume, Akihiko Gemma, Kozui Kida & Naoyuki Taniguchi. (2014) Association of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary disease. Physiological Reports 2:7, pages e12069.
Crossref
Crossref
Lucas M.A. Goossens, Cecile M.A. Utens, Frank W.J.M. Smeenk, Bas Donkers, Onno C.P. van Schayck & Maureen P.M.H. Rutten-van Mölken. (2014) Should I Stay or Should I Go Home? A Latent Class Analysis of a Discrete Choice Experiment on Hospital-At-Home. Value in Health 17:5, pages 588-596.
Crossref
Crossref
Francesco Blasi, Giancarlo Cesana, Sara Conti, Virginio Chiodini, Stefano Aliberti, Carla Fornari & Lorenzo Giovanni Mantovani. (2014) The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients. PLoS ONE 9:6, pages e101228.
Crossref
Crossref
Marlies Zwerink, Marjolein Brusse-Keizer, Paul DLPM van der Valk, Gerhard A Zielhuis, Evelyn M Monninkhof, Job van der Palen, Peter A Frith & Tanja Effing. (2014) Self management for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
J. Cruz, D. Brooks & A. Marques. (2014) Home telemonitoring effectiveness in COPD: a systematic review. International Journal of Clinical Practice 68:3, pages 369-378.
Crossref
Crossref
Björn Ställberg, Christer Janson, Gunnar Johansson, Kjell Larsson, Georgios Stratelis, Gunilla Telg & Karin H Lisspers. (2013) Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Primary Care Respiratory Journal 23:1, pages 38-45.
Crossref
Crossref
Antonio Anzueto, Dennis E. Niewoehner, Inge Leimer, Fee Rühmkorf, Bartolome R. Celli, Marc Decramer & Donald P. Tashkin. (2013) A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium. Respiratory Medicine 107:12, pages 1912-1922.
Crossref
Crossref
Cecile M.A. Utens, Lucas M.A. Goossens, Onno C.P. van Schayck, Maureen P.M.H. Rutten-van M?lken, Walter van Litsenburg, Annet Janssen, Anouschka van der Pouw & Frank W.J.M. Smeenk. (2013) Patient preference and satisfaction in hospital-at-home and usual hospital care for COPD exacerbations: Results of a randomised controlled trial. International Journal of Nursing Studies 50:11, pages 1537-1549.
Crossref
Crossref
Lucas M.A. Goossens, Cecile M.A. Utens, Frank W.J.M. Smeenk, Onno C.P. van Schayck, Monique van Vliet, Walter van Litsenburg, Maria W. Braken & Maureen P.M.H. Rutten-van M?lken. (2013) Cost-Effectiveness of Early Assisted Discharge for COPD Exacerbations in The Netherlands. Value in Health 16:4, pages 517-528.
Crossref
Crossref
Mehmet Polatli, Ali Ben Kheder, Siraj Wali, Arshad Javed, Adel Khattab, Bassam Mahboub, Ghali Iraqi, Chakib Nejjari, Samya Taright, Marie-Louise Koniski, Nauman Rashid & Abdelkader El Hasnaoui. (2012) Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: The BREATHE study. Respiratory Medicine 106, pages S75-S85.
Crossref
Crossref
Jake K. Nikota & Martin R. Stämpfli. (2012) Cigarette smoke-induced inflammation and respiratory host defense: Insights from animal models. Pulmonary Pharmacology & Therapeutics 25:4, pages 257-262.
Crossref
Crossref
Jane Cross. (2012) Chest physiotherapy during an acute exacerbation of chronic obstructive pulmonary disease. Chronic Respiratory Disease 9:2, pages 73-75.
Crossref
Crossref
Maureen P.M.H. Rutten-van Mölken & Lucas M.A. Goossens. (2012) Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease. PharmacoEconomics 30:4, pages 271-302.
Crossref
Crossref
Amir Sharafkhaneh, John G. Southard, Mitchell Goldman, Tom Uryniak & Ubaldo J. Martin. (2012) Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study. Respiratory Medicine 106:2, pages 257-268.
Crossref
Crossref
Richard A MularskiMary Ann McBurniePeter K Lindenauer, Todd A Lee, William M VollmerDavid H Au, Shannon S Carson & Jerry A Krishnan. (2012) Comparative effectiveness research in chronic obstructive pulmonary disease. Journal of Comparative Effectiveness Research 1:1, pages 71-82.
Crossref
Crossref
Douglas W Mapel, Michael P Dutro, Jenő P Marton, Kimberly Woodruff & Barry Make. (2011) Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Services Research 11:1.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Allergy & Clinical Immunology 11:3, pages 269-273.
Crossref
Crossref
Rik JB Loymans, Gerben ter Riet & Peter J Sterk. (2011) Definitions of asthma exacerbations. Current Opinion in Allergy & Clinical Immunology 11:3, pages 181-186.
Crossref
Crossref
Konstantinos Kostikas & Demosthenes Bouros. (2010) "Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD. BMC Pulmonary Medicine 10:1.
Crossref
Crossref